Blaze Bioscience gets Fast Track approval from FDA for ‘Tumor Paint’ that helps remove brain tumors Seattle biotech company Blaze Bioscience has received Fast Track designation from the FDA for a clinical program evaluating tozuleristide. Update, April 8: Blaze… Read More
Vote for Health Innovation of the Year: Tech and life sciences unite at the 2020 GeekWire Awards Editor’s note: The GeekWire Awards are now virtual on July 23. Watch live below. Technology is increasingly influencing the science… Read More
Seattle startup Blaze Bioscience makes brain tumors ‘light up like a Christmas tree’ in first trial Blaze Bioscience, a Seattle-based biotech company that’s using a protein borrowed from scorpion venom to make cancerous tumors glow, has… Read More
How scorpion venom helps improve brain cancer surgery in children by making tumors glow Seattle biotech company Blaze Bioscience has raised $5 million in funding as it pursues a pivotal trial for its “Tumor Paint,”… Read More
